Vascular Intervention

View all - Anticoagulation Antiplatelet DOAC

View all - Demographic Age Gender Ethnicity

View all - Heterogeneous Populations Inherited and Congenital Cardiac Conditions Congenital Heart Disease

View all - Vascular Disease and Surgery Aortic Disease - General Carotid Artery Disease Stroke Peripheral Artery Disease - General Occlusive Venous Disease - General Pulmonary Embolism Deep Vascular Intervention Endovascular Techniques

View all - Standards & Guidelines

View all - Imaging & Diagnostics Angiography CT/MRI Echocardiography & Ultrasound Nuclear

View all - Heart Failure Amyloidosis Paediatric Heart Failure Imaging and Diagnosis Devices Co-morbidities Cardiomyopathy Advancement in Heart Failure

View all - Electrophysiology & Arrhythmia Ventricular Arrhythmias Supraventricular Tachycardia Stroke Prevention in Atrial Fibrillation Reversal Agents Pacing, Defibrillators & Cardiac Resynchronisation Therapy Catheter Ablation of Cardiac Arrhythmias Real World Contact Force Ablation Persistent Atrial Fibrillation Using Arctic Front™ Cardiac Cryoablation System Atrial Fibrillation Atrial Arrhythmias Sudden Cardiac Death

View all - Digital Health

View all - COVID-19

View all - Prevention & Chronic Conditions Angina Cardiac Rehabilitation Programmes Chronic Kidney Disease Coronary Artery Disease and Myocardial Infarction Atherosclerosis and Hyperlipidemia Diabetes Hypertension Hypertension Management Pulmonary Arterial Hypertension Lifestyle Nonalcoholic Steatohepatitis (NASH) Obesity Stroke

View all - Pericardium Disorders

View all - MI/ACS Unstable Angina & NSTEMI STEMI

View all - Intervention Drug-eluting balloons Structural Intervention Peripheral Intervention Coronary Interventions Transradial Intervention Intravascular Imaging Coronary Physiology Bifurcation

View all - CV Disease in Special Populations Cardio-oncology Amyloidosis Cardiotoxicity Clinical Practice

Vascular Intervention

Most Recent Most Viewed

Topics

Video

Vascular Disease and Surgery

Electrophysiology & Arrhythmia

EHRA 24: The Style-AF Study

Roland R Tilz,

Watch time: 4m 54s

Video

Vascular Disease and Surgery

Intervention

CRT 24: The ABSORB Trial

David Power,

Watch time: 5m 50s

Article

Vascular Disease and Surgery

Intervention

Cerebral Embolic Protection Devices

Ankit Agrawal , Toshiaki Isogai , Shashank Shekhar , et al

Read time: 18m

USC Discussion 2022: Transcatheter Aortic Valve Replacement Optimization Strategies

Video

Vascular Disease and Surgery

Intervention

USC Discussion 22: TAVR Optimization Strategies

Hemal Gada, Kendra J Grubb,

Watch time: 21m 21s

HF 22: Rebalance-HF: Catheter-Based Ablation of the GSN in Pts with HFpEF

Video

Vascular Disease and Surgery

HF 22: Catheter-Based Ablation of the GSN in Pts with HFpEF

Marat Fudim,

Watch time: 7m 13s

Article

Vascular Disease and Surgery

Intervention

TAVR Optimization

Saima Siddique , Resha Khanal , Amit N Vora , et al

ACC 22: Results From the Chocolate-Touch Study

Video

Vascular Disease and Surgery

Intervention

ACC 22: Results From the Chocolate-Touch Study

Mehdi Shishehbor,

Watch time: 5m 41s

Article

Vascular Disease and Surgery

Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement

Eden C Payabyab , Lindsay S Elbaum , Navneet Sharma , et al

AHA 21: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism

Video

Vascular Disease and Surgery

AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of VTE

Jeffrey Weitz,

Watch time: 7m 58s

Article

Vascular Disease and Surgery

Intervention

Cerebral Embolic Protection Devices

Ankit Agrawal , Toshiaki Isogai , Shashank Shekhar , et al

Read time: 18m

Article

Vascular Disease and Surgery

Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement

Eden C Payabyab , Lindsay S Elbaum , Navneet Sharma , et al

Article

Vascular Disease and Surgery

Intervention

TAVR Optimization

Saima Siddique , Resha Khanal , Amit N Vora , et al

Video

Vascular Disease and Surgery

AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of VTE

Jeffrey Weitz,

Watch time: 7m 58s

Video

Vascular Disease and Surgery

Intervention

USC Discussion 22: TAVR Optimization Strategies

Hemal Gada, Kendra J Grubb,

Watch time: 21m 21s

Video

Vascular Disease and Surgery

Intervention

ACC 22: Results From the Chocolate-Touch Study

Mehdi Shishehbor,

Watch time: 5m 41s

Video

Vascular Disease and Surgery

HF 22: Catheter-Based Ablation of the GSN in Pts with HFpEF

Marat Fudim,

Watch time: 7m 13s

Video

Vascular Disease and Surgery

Electrophysiology & Arrhythmia

EHRA 24: The Style-AF Study

Roland R Tilz,

Watch time: 4m 54s

Video

Vascular Disease and Surgery

Intervention

CRT 24: The ABSORB Trial

David Power,

Watch time: 5m 50s

Media

Video

Vascular Disease and Surgery

AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of VTE

Jeffrey Weitz,

Watch time: 7m 58s

Media

Video

Vascular Disease and Surgery

Electrophysiology & Arrhythmia

EHRA 24: The Style-AF Study

Roland R Tilz,

Watch time: 4m 54s

Video

Vascular Disease and Surgery

Intervention

CRT 24: The ABSORB Trial

David Power,

Watch time: 5m 50s

Video

Vascular Disease and Surgery

AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of VTE

Jeffrey Weitz,

Watch time: 7m 58s

Video

Vascular Disease and Surgery

Intervention

ACC 22: Results From the Chocolate-Touch Study

Mehdi Shishehbor,

Watch time: 5m 41s

Video

Vascular Disease and Surgery

HF 22: Catheter-Based Ablation of the GSN in Pts with HFpEF

Marat Fudim,

Watch time: 7m 13s

Video

Vascular Disease and Surgery

Intervention

USC Discussion 22: TAVR Optimization Strategies

Hemal Gada, Kendra J Grubb,

Watch time: 21m 21s

Articles

Cerebral Embolic Protection Devices

Published:

31 March 2023

Citation:

US Cardiology Review 2023;17;e02.

DOI:

https://doi.org/10.15420/usc.2022.12

Abstract
Full text
Login or register to view PDF.
Permissions
References

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Views: 2704
Downloads: 128
Citations: 3
Read time: 18m